OPINION
By Amanda Bresnan
There's been a major campaign undertaken by people living with Hepatitis C, the medical community, and the organisations who represent and advocate on behalf of people living with hepatitis C, to have these new drugs listed on the Pharmaceutical Benefits Scheme (PBS).
These Hepatitis C treatments have already been approved by the PBAC and the reason for the delay in providing them to patients is the ongoing negotiations with the product sponsors over price.
The federal Health Minister, Sussan Ley, previously made some positive statements which suggested the possibility of treatments being listed by December 2015; however, this listing is looking less and less likely to occur....
No comments:
Post a Comment